ORUM - Asset Resilience Ratio

Latest as of March 2026: 51.51%

ORUM (475830) has an Asset Resilience Ratio of 51.51% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 475830 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩161.13 Billion

≈ $109.19 Million USD Cash + Short-term Investments

Total Assets

₩312.82 Billion

≈ $211.99 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2025)

This chart shows how ORUM's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see ORUM assets under control.

Liquid Assets Composition Over Time

This chart breaks down ORUM's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read ORUM (475830) total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩161.13 Billion	51.51%
Total Liquid Assets	₩161.13 Billion	51.51%

Asset Resilience Insights

Very High Liquidity: ORUM maintains exceptional liquid asset reserves at 51.51% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

ORUM Industry Peers by Asset Resilience Ratio

Compare ORUM's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
ALK-Abelló A/S CO:ALK-B	Biotechnology	0.98%
Mirum Pharmaceuticals Inc NASDAQ:MIRM	Biotechnology	6.89%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
BB Biotech AG SW:BION	Biotechnology	92.97%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Beijing Konruns Pharmaceutical Co Ltd SHG:603590	Biotechnology	10.55%

Annual Asset Resilience Ratio for ORUM (2022–2025)

The table below shows the annual Asset Resilience Ratio data for ORUM.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	75.91%	₩128.54 Billion ≈ $87.11 Million	₩169.32 Billion ≈ $114.75 Million	-0.60pp
2024-12-31	76.51%	₩117.70 Billion ≈ $79.76 Million	₩153.84 Billion ≈ $104.25 Million	-1.78pp
2023-12-31	78.29%	₩126.66 Billion ≈ $85.83 Million	₩161.78 Billion ≈ $109.64 Million	+21.51pp
2022-12-31	56.78%	₩12.09 Billion ≈ $8.19 Million	₩21.28 Billion ≈ $14.42 Million	--

pp = percentage points

About ORUM

KQ:475830 Korea Biotechnology

Market Cap

$768.37 Million

₩1.13 Trillion KRW

Market Cap Rank

#10152 Global

#269 in Korea

Share Price

₩53400.00

Change (1 day)

+5.33%

52-Week Range

₩31800.00 - ₩143700.00

All Time High

₩143700.00